Merck & Co Inc
NYSE:MRK

Watchlist Manager
Merck & Co Inc Logo
Merck & Co Inc
NYSE:MRK
Watchlist
Price: 108.93 USD 0.09%
Market Cap: 270.4B USD

Profitability Summary

Merck & Co Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Merck & Co Inc

Margins Comparison
Merck & Co Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Merck & Co Inc
NYSE:MRK
270.2B USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
524.3B USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
378B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
273.4B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
155.6B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.7B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
111.7B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
111.1B USD
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Merck & Co Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Merck & Co Inc
NYSE:MRK
270.2B USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
524.3B USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
378B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
273.4B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
155.6B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.7B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
111.7B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
111.1B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Merck & Co Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate